efficacy against s pneumoniae atcc 10813 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
94
Structured Review
ATCC
efficacy against s pneumoniae atcc 10813
Efficacy Against S Pneumoniae Atcc 10813, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 54 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/efficacy+against+s+pneumoniae+atcc+10813/Streptococcus+pneumoniae+(Klein)+Chester/pmc02565885-130-49-53
Average 94 stars, based on 54 article reviews
Efficacy Against S Pneumoniae Atcc 10813, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 54 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/efficacy+against+s+pneumoniae+atcc+10813/Streptococcus+pneumoniae+(Klein)+Chester/pmc02565885-130-49-53
Average 94 stars, based on 54 article reviews
efficacy against s pneumoniae atcc 10813 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Infection:Article Title: Pharmacodynamics of the New Des-F(6)-Quinolone Garenoxacin in a Murine Thigh Infection Model Article Snippet: .. These analyses suggest that treatment efficacy was dependent upon dose level and independent of the dosing intervals studied. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3. caption a7 (a) The relationship between the garenoxacin dosing interval and Article Title: In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models Article Snippet: .. Figure illustrates the relationship between T > MIC and the activity of ceftobiprole against these two organisms at both sites of infection. fig ft0 fig mode=article f1 FIG. 4. caption a4 Relationship of T > MIC for 6-h dosing of increasing doses of ceftobiprole with its Article Title: Pharmacodynamics of a New Cephalosporin, PPI-0903 (TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and Lung Infection Models: Identification of an In Vivo Pharmacokinetic-Pharmacodynamic Target Article Snippet: .. These dose regimen relationships indicate that treatment efficacy was dependent upon the dosing intervals studied and suggest that efficacy was driven by the %T>MIC index. fig ft0 fig mode=article f1 FIG.3. caption a4 Relationship between PPI-0903 dosing interval and Activity Assay:Article Title: In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models Article Snippet: .. Figure illustrates the relationship between T > MIC and the activity of ceftobiprole against these two organisms at both sites of infection. fig ft0 fig mode=article f1 FIG. 4. caption a4 Relationship of T > MIC for 6-h dosing of increasing doses of ceftobiprole with its Article Title: In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models Article Snippet: .. Figure illustrates the relationship between T > MIC and the activity of ceftobiprole against these two organisms in thighs of mice with and without neutropenia. fig ft0 fig mode=article f1 FIG. 5. caption a4 Relationship of T > MIC for 6-h dosing of increasing doses of ceftobiprole with its Protein-Protein interactions:Article Title: Pharmacodynamics of a New Cephalosporin, PPI-0903 (TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and Lung Infection Models: Identification of an In Vivo Pharmacokinetic-Pharmacodynamic Target Article Snippet: .. These dose regimen relationships indicate that treatment efficacy was dependent upon the dosing intervals studied and suggest that efficacy was driven by the %T>MIC index. fig ft0 fig mode=article f1 FIG.3. caption a4 Relationship between PPI-0903 dosing interval and |